Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: Evidence for the role of TNF-α and cyclooxygenase-2

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 8119-8127

  Steenport, Michel ^a   Khan, K M Faisal ^a   Du, Baoheng ^a   Barnhard, Sarah E ^a   Dannenberg, Andrew J ^a   Falcone, Domenick J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN G; INTERSTITIAL COLLAGENASE; PROSTAGLANDIN E2; PROSTANOID; SMALL INTERFERING RNA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; MMP1 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PTGS2 PROTEIN, HUMAN; TNF PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOCKING FACTOR; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; TIGHT JUNCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHRONIC DISEASE; ENZYMOLOGY; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SECRETION;

ANIMALS; CELL LINE; CHRONIC DISEASE; CYCLOOXYGENASE 2; ENZYME INDUCTION; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MACROPHAGES, PERITONEAL; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASMS; RECEPTORS, PROSTAGLANDIN E; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76249133494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901925     Document Type: Article

References (54)

1. Opdenakker, G., P. E. Van den Steen, and J. Van Damme. 2001. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22: 571-579. (Pubitemid 33016405)
2. Parks, W. C., C. L. Wilson, and Y. S. Lopez-Boado. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4: 617-629. (Pubitemid 39025047)
3. Deryugina, E. I., and J. P. Quigley. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25: 9-34.
4. Khan, K. M. F., L. R. Howe, and D. J. Falcone. 2004. Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J. Biol. Chem. 279: 22039-22046.
5. 2 receptors as an alternative strategy to block cyclooxygenase-2- dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J. Biol. Chem. 281: 3321-3328.
6. Dreier, R., S. Wallace, S. Fuchs, P. Bruckner, and S. Grassel. 2001. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J. Cell Sci. 114: 3812-3822. (Pubitemid 33094696)
7. Ramos-DeSimone, N., E. Hahn-Dantona, J. Sipley, H. Nagase, D. L. French, and J. P. Quigley. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274: 13066-13076. (Pubitemid 29220428)
8. Edelson, P. J., and Z. A. Cohn. 1976. Purification and cultivation of monocytes and macrophages. In In Vitro Methods in Cell Mediated Tumor Immunity. B. R. Bloom and J. R. David, eds. Academic, New York, pp. 333-340.
9. Falcone, D. J., and M. J. Ferenc. 1988. Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix. J. Cell. Physiol. 135: 387-396.
10. Raschke, W. C., S. Baird, P. Ralph, and I. Nakoinz. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15: 261-267. (Pubitemid 9027529)
11. Visse, R., and H. Nagase. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92: 827-839. (Pubitemid 36542523)
12. 2 over thromboxane and prostaglandin D-2 in lipopolysaccharide- stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 230: 110-114.
13. Vogel, S., M. J. Hirschfeld, and P. Y. Perera. 2001. Signal integration in lipopolysaccharide (LPS)-stimulated murine macrophages. J. Endotoxin Res. 7: 237-241. (Pubitemid 32894580)
14. Ogata, Y., Y. Itoh, and H. Nagase. 1995. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270: 18506-18511.
15. Goldberg, G. I., A. Strongin, I. E. Collier, L. T. Genrich, and B. L. Marmer. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267: 4583-4591.
16. 2 enhances intestinal adenoma growth via activation of the Rasmitogen-activated protein kinase cascade. Cancer Res. 65: 1822-1829.
17. Breyer, R. M., C. K. Bagdassarian, S. A. Myers, and M. D. Breyer. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41: 661-690.
18. Hata, A. N., and R. M. Breyer. 2004. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103: 147-166.
19. Cipollone, F., M. L. Fazia, A. Iezzi, C. Cuccurullo, D. De Cesare, S. Ucchino, F. Spigonardo, A. Marchetti, F. Buttitta, L. Paloscia, et al. 2005. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler. Thromb. Vasc. Biol. 25: 1925-1931.
20. Saksela, O., and D. B. Rifkin. 1990. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110: 767-775.
21. Sahin, U., G. Weskamp, K. Kelly, H. M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, and C. P. Blobel. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164: 769-779.
22. Falcone, D. J., T. A. McCaffrey, A. Haimovitz-Friedman, J.-A. Vergilio, and A. C. Nicholson. 1993. Macrophage and foam cell release of matrix bound growth factors: role of plasminogen activation. J. Biol. Chem. 268: 11951-11958.
23. Gearing, A. J., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, et al. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370: 555-557.
24. Mohan, M. J., T. Seaton, J. Mitchell, A. Howe, K. Blackburn, W. Burkhart, M. Moyer, I. Patel, G. M. Waitt, J. D. Becherer, et al. 2002. The tumor necrosis factor-α converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41: 9462-9469.
25. Giannelli, G., J. Falk-Marzillier, O. Schiraldi, W. G. Stetler-Stevenson, and V. Quaranta. 1997. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225-228.
26. Khan, K. M. F., G. W. Laurie, T. A. McCaffrey, and D. J. Falcone. 2002. Exposure of cryptic domains in the α1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J. Biol. Chem. 277: 13778-13786.
27. Adair-Kirk, T. L., J. J. Atkinson, D. G. Kelley, R. H. Arch, J. H. Miner, and R. M. Senior. 2005. A chemotactic peptide from laminin α5 functions as a regulator of inflammatory immune responses via TNFα-mediated signaling. J. Immunol. 174: 1621-1629.
28. Coughlin, S. R. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Throm. Haemost. 3: 1800-1814.
29. Boire, A., L. Covic, A. Agarwal, S. Jacques, S. Sherifl, and A. Kuliopulos. 2005. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumor-igenesis of breast cancer cells. Cell 120: 303-313.
30. Wu, M. H., H. S. Sun, C. C. Lin, K. Y. Hsiao, P. C. Chuang, H. A. Pan, and S. J. Tsai. 2002. Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. Mol. Hum. Reprod. 8: 1103-1110.
31. Heidinger, M., H. Kolb, H. W. Krell, M. Jochum, and C. Ries. 2006. Modulation of autocrine TNF-α-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biol. Chem. 387: 69-78.
32. Barrios-Rodiles, M., G. Tiraloche, and K. Chadee. 1999. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1β and TNF-α. J. Immunol. 163: 963-969.
33. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. S. Moore, Z. Werb, and S. Rafii. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 109: 625-637.
34. Ducharme, A., S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L. E. Rohde, F. J. Schoen, R. A. Kelly, Z. Werb, P. Libby, and R. T. Lee. 2000. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106: 55-62.
35. Okada, Y., Y. Gonoji, K. Naka, K. Tomita, I. Nakanishi, K. Iwata, K. Yamashita, and T. Hayakawa. 1992. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267: 21712-21719.
36. 2 synthases. Clin. Immunol. 119: 229-240.
37. Trebino, C. E., J. L. Stock, C. P. Gibbons, B. M. Naiman, T. S. Wachtmann, J. P. Umland, K. Pandher, J. M. Lapointe, S. Saha, M. L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100: 9044-9049.
38. 2 as a mediator of fever: synthesis and catabolism. Front. Biosci. 9: 1977-1993.
39. Corcoran, M. L., W. G. Stetler-Stevenson, D. L. DeWitt, and L. M. Wahl. 1994. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Archives Biochem. Biophys. 310: 481-488.
40. Shankavaram, U. T., D. L. DeWitt, S. E. Funk, E. H. Sage, and L. M. Wahl. 1997. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell. Physiol. 173: 327-334.
41. Ottino, P., and H. E. P. Bazan. 2001. Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites. Curr. Eye Res. 23: 77-85.
42. 2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem. 277: 50828-50833.
43. Hla, T., D. Bishop-Bailey, C. H. Liu, H. L. Schaefers, and O. C. Trifan. 1999. Cyclooxygenase-1 and -2 isoenzymes. Int. J. Biochem. Cell Biol. 31: 551-557.
44. Smith, W. L., and R. Langenbach. 2001. Why there are two cyclooxygenase isozymes. J. Clin. Invest. 107: 1491-1495.
45. Hendrickx, N., C. Volanti, U. Moens, O. M. Seternes, P. De Witte, J. R. Vandenheede, J. Piette, and P. Agnostinis. 2003. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. 278: 52231-52239.
46. Pratt, P. F., D. Bokemeyer, M. Foschi, A. Sorokin, and M. J. Dunn. 2003. Alterations in subcellular localization of p38 MAPK potentiate endothelin-stimulated COX-2 expression in glomerular mesangial cells. J. Biol. Chem. 278: 51928-51936.
47. 2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33: 1244-1251.
48. Subbaramaiah, K., T. P. Marmo, D. A. Dixon, and A. J. Dannenberg. 2003. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J. Biol. Chem. 278: 37637-37647.
49. 2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts. J. Biol. Chem. 276: 31720-31731.
50. Moss, M. L., S. L. Jin, M. E. Milla, D. M. Bickett, W. Burkhart, H. L. Carter, W. J. Chen, W. C. Clay, J. R. Didsbury, D. Hassler, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385: 733-736.
51. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385: 729-733.
52. Edwards, D. R., M. M. Handsley, and C. J. Pennington. 2008. The ADAM metalloproteinases. Mol. Aspects Med. 29: 258-289.
53. Van Lint, P., and C. Libert. 2007. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukocyte Biol. 82: 1375-1381.
54. Fingleton, B. 2006. Matrix metalloproteinases: roles in cancer and metastasis. Front. Biosci. 11: 479-491.